Financials
- Market Capitalization 2.46 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1832 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.92 USD | +2.27% | +1.54% | +10.22% | +19.95% | 2.53 B USD | ||
| 1847 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.23 USD | +0.44% | -2.48% | +7.57% | +15.10% | 2.47 B USD | ||
| 1852 | NKTR Nektar Therapeutics - Common Stock | 71.75 USD | +0.52% | -3.31% | +1.46% | -2.07% | 2.45 B USD | ||
| 1863 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 41.25 USD | +4.75% | +3.77% | +16.39% | +33.50% | 2.40 B USD |